InVivoMAb anti-mouse CD80 (B7-1)

Marshall D, Sinclair C, Tung S, et al. Differential requirement for IL-2 and IL-15 during bifurcated development of thymic regulatory T cells. J Immunol. 2014,193(11):5525-33. doi: 10.4049/jimmunol.1402144

Moser EK, Hufford MM, Braciale TJ. Late engagement of CD86 after influenza virus clearance promotes recovery in a FoxP3+ regulatory T cell dependent manner. PLoS Pathog. 2014,10(8):e1004315. doi: 10.1371/journal.ppat.1004315

Srivastava S, Koch MA, Pepper M, et al. Type I interferons directly inhibit regulatory T cells to allow optimal antiviral T cell responses during acute LCMV infection. J Exp Med. 2014,211(5):961-74. doi: 10.1084/jem.20131556

Arjunaraja S, Paoletti LC, Snapper CM. Structurally identical capsular polysaccharide expressed by intact group B streptococcus versus Streptococcus pneumoniae elicits distinct murine polysaccharide-specific IgG responses in vivo. J Immunol. 2012,188(11):5238-46. doi: 10.4049/jimmunol.1200132

Rockett BD, Salameh M, Carraway K, et al. n-3 PUFA improves fatty acid composition, prevents palmitate-induced apoptosis, and differentially modifies B cell cytokine secretion in vitro and ex vivo. J Lipid Res. 2010,51(6):1284-97. doi: 10.1194/jlr.M000851